Assignee
CRITITECH INC
US·33 granted patents·24 pending applications·304 citations·filing 2007–2025
Top patents by PatentIndex Score
57 records- 0197US9814685B2Taxane particles and their useCRITITECH INC·Filed 2016·Granted Nov 14, 2017·40 cites·18 claims
- 0296US10729673B2Taxane particles and their useCRITITECH INC·Filed 2020·Granted Aug 4, 2020·11 cites·22 claims
- 0396US10391090B2Methods for solid tumor treatmentCRITITECH INC·Filed 2018·Granted Aug 27, 2019·16 cites·26 claims
- 0496US9918957B2Methods for making compound particlesCRITITECH INC·Filed 2017·Granted Mar 20, 2018·23 cites·18 claims
- 0596US7744923B2Method for precipitation of small medicament particles into use containersCRITITECH INC·Filed 2007·Granted Jun 29, 2010·48 cites·34 claims
- 0695US10894045B2Methods for solid tumor treatmentCRITITECH INC·Filed 2019·Granted Jan 19, 2021·11 cites·22 claims
- 0795US10874660B2Methods for solid tumor treatmentCRITITECH INC·Filed 2019·Granted Dec 29, 2020·10 cites·20 claims
- 0895US10507195B2Taxane particles and their useCRITITECH INC·Filed 2018·Granted Dec 17, 2019·18 cites·28 claims
- 0994US10507181B2Methods for treating lung disordersCRITITECH INC·Filed 2019·Granted Dec 17, 2019·10 cites·23 claims
- 1094US10398646B2Methods for treating lung disordersCRITITECH INC·Filed 2018·Granted Sep 3, 2019·10 cites·20 claims
- 1193US8778181B1Equipment assembly for and method of processing particlesCRITITECH INC·Filed 2013·Granted Jul 15, 2014·64 cites·28 claims
- 1292US9233348B2Equipment assembly for and method of processing particlesCRITITECH INC·Filed 2014·Granted Jan 12, 2016·32 cites·25 claims
- 1391US11123322B2Taxane particles and their useCRITITECH INC·Filed 2019·Granted Sep 21, 2021·2 cites·18 claims
- 1490US2025186390A1Taxane Particles and Their UseCRITITECH INC·Filed 2024·Application pending·0 cites
- 1589US11033542B2Methods for solid tumor treatmentCRITITECH INC·Filed 2019·Granted Jun 15, 2021·2 cites·24 claims
- 1686US12329858B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2024·Granted Jun 17, 2025·0 cites·19 claims
- 1786US10993927B2Taxane particles and their useCRITITECH INC·Filed 2020·Granted May 4, 2021·1 cites·18 claims
- 1884US11458133B2Methods for solid tumor treatmentCRITITECH INC·Filed 2020·Granted Oct 4, 2022·1 cites·22 claims
- 1984US11058639B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2020·Granted Jul 13, 2021·1 cites·24 claims
- 2084US9925512B2Equipment assembly for and method of processing particlesCRITITECH INC·Filed 2015·Granted Mar 27, 2018·3 cites·22 claims
- 2183US12128131B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2023·Granted Oct 29, 2024·0 cites·18 claims
- 2282US12390459B2Methods for solid tumor treatmentCRITITECH INC·Filed 2022·Granted Aug 19, 2025·0 cites·20 claims
- 2382US10751319B2Collection device and methods for useCRITITECH INC·Filed 2016·Granted Aug 25, 2020·1 cites·14 claims
- 2480US11918691B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2023·Granted Mar 5, 2024·0 cites·14 claims
- 2580US11737972B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·18 claims
- 2679US2021393569A1Taxane Particles and Their UseCRITITECH INC·Filed 2021·Application pending·0 cites
- 2775US11160754B2Methods for treating lung disordersCRITITECH INC·Filed 2019·Granted Nov 2, 2021·0 cites·25 claims
- 2874US11583499B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2021·Granted Feb 21, 2023·0 cites·21 claims
- 2974US2024226116A1Glucocorticoid Particles and Their UseCRITITECH INC·Filed 2024·Application pending·0 cites
- 3074US2020405684A1Taxane Particles and Their UseCRITITECH INC·Filed 2020·Application pending·0 cites
- 3173US12029818B2Lapatinib particles and uses thereofCRITITECH INC·Filed 2022·Granted Jul 9, 2024·0 cites·17 claims
- 3273US11523983B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2021·Granted Dec 13, 2022·0 cites·18 claims
- 3370US2019254957A1Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 3470US2022096423A1Treatment of Bladder Cancer by Local Administration of Taxane ParticlesCRITITECH INC·Filed 2021·Application pending·0 cites
- 3570US2025360166A1Cisplatin particles and uses thereofCRITITECH INC·Filed 2025·Application pending·0 cites
- 3668US11738014B2Niraparib particles and uses thereofCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·17 claims
- 3768US11738029B2Rucaparib particles and uses thereofCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·17 claims
- 3868US11291646B2Nozzle assembly and methods for useCRITITECH INC·Filed 2016·Granted Apr 5, 2022·0 cites·22 claims
- 3967US11931368B2Glucocorticoid “nintedanib” particles and their useCRITITECH INC·Filed 2018·Granted Mar 19, 2024·0 cites·8 claims
- 4067US2019209515A1Treatment of Bladder Cancer by Intratumoral Injection of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 4167US2019209514A1Treatment of Bladder Cancer by Local Administration of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 4266US11104663B2Ciprofloxacin polymorph and its useCRITITECH INC·Filed 2018·Granted Aug 31, 2021·0 cites·19 claims
- 4365US2024216424A1Cisplatin particles and uses thereofCRITITECH INC·Filed 2022·Application pending·0 cites
- 4463US2016374953A1Methods for Making Compound ParticlesCRITITECH INC·Filed 2016·Application pending·0 cites
- 4563US2021387961A1Ciprofloxacin polymorph and its useCRITITECH INC·Filed 2021·Application pending·0 cites
- 4662US2024156861A1Cisplatin particles and uses thereofCRITITECH INC·Filed 2023·Application pending·0 cites
- 4762US2023364021A1Sorafenib particles and uses thereofCRITITECH INC·Filed 2023·Application pending·0 cites
- 4861US2022023215A1Lapatinib particles and uses thereofCRITITECH INC·Filed 2021·Application pending·0 cites
- 4961US2021214683A1Methods for isolating tumor-specific immune cells from a subject for adoptive cell therapy and cancer vaccinesCRITITECH INC·Filed 2019·Application pending·0 cites
- 5058US2018221849A1Equipment Assembly for and Method of Processing ParticlesCRITITECH INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CRITITECH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →